Kayla Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kayla Zhang has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Manali Mukherjee
Department of Medicine, McMaster University
3 shared publications - Anna Dvorkin-Gheva
Firestone Institute for Respiratory Health, St Joseph's Healthcare Hamilton, Hamilton, Canada
2 shared publications Katherine Radford
Firestone Institute for Respiratory Health, St Joseph's Healthcare Hamilton, Hamilton, Canada
2 shared publications- Parameswaran Nair
Division of Respirology, St Joseph’s Healthcare & McMaster University
2 shared publications - Sarah Svenningsen
Medicine, McMaster University, Hamilton, Ontario, Canada
2 shared publications - Anna Dvorkin-Gheva
Medicine, McMaster University, Hamilton, Canada, Canada
1 shared publication
Latest Publications
- Open Access
- 15 September 2026
- Published by MDPI AG in Preprints.org
Induction of sFRP1 Expression and Modulation of Wnt Signaling in Mouse Lung Inflammation by Oncostatin M In Vivo
Wnt signaling plays central roles in embryogenesis/development, skeletal homeostasis, tumour development, and other diseases. The pathway is initiated by Wnt ligands which can be bound and inhibited by sFRP1. Regulation of sFRP1 in lung inflammation needs increased study, and little is known about which cytokines can induce sFRP1, nor the role of gp130 cytokines in its modulation. Here we used AdOSM (Advector expressing mouse Oncostatin M [OSM]) administration to overexpress the gp130 cytokine OSM in mice in vivo, and applied Nanostring, RT-PCR, and immunoblots to measure mRNA and protein levels. OSM induced robust increases in mRNA for sFRP-1 in context of reduced Wnt ligand and receptor mRNA (Wnt10B, Wnt3A, Wnt2, Wnt11, LRP5 and LRP6). Axin-2 mRNA, as a b-catenin target gene, was also suppressed suggesting an inhibition of Wnt signaling pathways. AdOSM could induce sFRP1 in IL-6KO mice, while overexpression of IL-6 (AdIL-6 vector) did not. Immunoblots of total lung extracts showed increases in the 35Kd sFRP1 protein species. In situ hybridization of mouse lung histological sections using specific sFRP1 probes showed staining in the subepithelial layer of the airways, consistent with fibroblast or myofibroblast locations in lung mucosa. In vitro, recombinant OSM stimulated sFRP1 mRNA in cultures of mouse lung fibroblasts and NIH-3T3 cells. The results support the novel observation that OSM can induce sFRP1 in vitro and in vivo, and suggest this axis contributes to the control of Wnt signaling pathways in lung inflammation.
- 15 September 2026
- Published by MDPI AG in Preprints.org
Open AccessInduction of sFRP1 Expression and Modulation of Wnt Signaling in Mouse Lung Inflammation by Oncostatin M In Vivo
Wnt signaling plays central roles in embryogenesis/development, skeletal homeostasis, tumour development, and other diseases. The pathway is initiated by Wnt ligands which can be bound and inhibited by sFRP1. Regulation of sFRP1 in lung inflammation needs increased study, and little is known about which cytokines can induce sFRP1, nor the role of gp130 cytokines in its modulation. Here we used AdOSM (Advector expressing mouse Oncostatin M [OSM]) administration to overexpress the gp130 cytokine OSM in mice in vivo, and applied Nanostring, RT-PCR, and immunoblots to measure mRNA and protein levels. OSM induced robust increases in mRNA for sFRP-1 in context of reduced Wnt ligand and receptor mRNA (Wnt10B, Wnt3A, Wnt2, Wnt11, LRP5 and LRP6). Axin-2 mRNA, as a b-catenin target gene, was also suppressed suggesting an inhibition of Wnt signaling pathways. AdOSM could induce sFRP1 in IL-6KO mice, while overexpression of IL-6 (AdIL-6 vector) did not. Immunoblots of total lung extracts showed increases in the 35Kd sFRP1 protein species. In situ hybridization of mouse lung histological sections using specific sFRP1 probes showed staining in the subepithelial layer of the airways, consistent with fibroblast or myofibroblast locations in lung mucosa. In vitro, recombinant OSM stimulated sFRP1 mRNA in cultures of mouse lung fibroblasts and NIH-3T3 cells. The results support the novel observation that OSM can induce sFRP1 in vitro and in vivo, and suggest this axis contributes to the control of Wnt signaling pathways in lung inflammation.
- Open Access
- 26 February 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (4)
Cell-free tumour DNA in bronchoalveolar lavage: a proof of concept study
Extract Molecular analysis is increasingly integral to lung cancer evaluation and management [1]. While evidence of circulating tumor DNA (ctDNA) has existed for decades [2], research in this field centers on ctDNA detection primarily in peripheral blood, which may present limitations. These include reduced sensitivity [3, 4], the potential of false negatives due to low tumor burden or shedding [5], and the possibility that lung compartmentalization may prevent cancer cells from appearing in systematic circulation [6]. We hypothesized that bronchoalveolar lavage (BAL) would exhibit an enrichment of lung cancer-derived cell-free DNA (cfDNA) detectable using digital PCR (dPCR), a precise method for nucleic acid quantification.
- 26 February 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (4)
Open AccessCell-free tumour DNA in bronchoalveolar lavage: a proof of concept study
Extract Molecular analysis is increasingly integral to lung cancer evaluation and management [1]. While evidence of circulating tumor DNA (ctDNA) has existed for decades [2], research in this field centers on ctDNA detection primarily in peripheral blood, which may present limitations. These include reduced sensitivity [3, 4], the potential of false negatives due to low tumor burden or shedding [5], and the possibility that lung compartmentalization may prevent cancer cells from appearing in systematic circulation [6]. We hypothesized that bronchoalveolar lavage (BAL) would exhibit an enrichment of lung cancer-derived cell-free DNA (cfDNA) detectable using digital PCR (dPCR), a precise method for nucleic acid quantification.
- Top Cited Papers
- 15 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (781) , eado6649
A population of c-kit + IL-17A + ILC2s in sputum from individuals with severe asthma supports ILC2 to ILC3 trans-differentiation
In prednisone-dependent severe asthma, uncontrolled sputum eosinophilia is associated with increased numbers of group 2 innate lymphoid cells (ILC2s). These cells represent a relatively steroid-insensitive source of interleukin-5 (IL-5) and IL-13 and are considered critical drivers of asthma pathology. The abundance of ILC subgroups in severe asthma with neutrophilic or mixed granulocytic (both eosinophilic and neutrophilic) airway inflammation, prone to recurrent infective exacerbations, remains unclear. Here, we found by flow cytometry that sputum ILC3s are increased in severe asthma with intense airway neutrophilia, whereas equivalently raised sputum ILC2s and ILC3s were found in severe asthma with mixed granulocytic inflammation. Unbiased clustering analyses identified an “intermediate-ILC2” population displaying markers of both ILC2s (prostaglandin D 2 receptor 2; CRTH2, IL-5, and IL-13) and ILC3s (c-kit and IL-17A) that were most abundant in severe asthma with mixed granulocytic airway inflammation. Intermediate ILC2s correlated with airway neutrophilia and were associated with increased amounts of IL-1β and IL-18 in sputum supernatants. Coculture of sort-purified canonical ILC2s with IL-1β and IL-18 in vitro up-regulated c-kit and IL-17A as well as gene expression profiles related to both type 2 and type 17 inflammatory pathways. Together, we have identified an intermediate-ILC2 phenotype in the airways of individuals with severe mixed granulocytic asthma, representing a candidate therapeutic target for controlling neutrophilic airway inflammation.
- 15 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (781) , eado6649
Top Cited PapersA population of c-kit + IL-17A + ILC2s in sputum from individuals with severe asthma supports ILC2 to ILC3 trans-differentiation
In prednisone-dependent severe asthma, uncontrolled sputum eosinophilia is associated with increased numbers of group 2 innate lymphoid cells (ILC2s). These cells represent a relatively steroid-insensitive source of interleukin-5 (IL-5) and IL-13 and are considered critical drivers of asthma pathology. The abundance of ILC subgroups in severe asthma with neutrophilic or mixed granulocytic (both eosinophilic and neutrophilic) airway inflammation, prone to recurrent infective exacerbations, remains unclear. Here, we found by flow cytometry that sputum ILC3s are increased in severe asthma with intense airway neutrophilia, whereas equivalently raised sputum ILC2s and ILC3s were found in severe asthma with mixed granulocytic inflammation. Unbiased clustering analyses identified an “intermediate-ILC2” population displaying markers of both ILC2s (prostaglandin D 2 receptor 2; CRTH2, IL-5, and IL-13) and ILC3s (c-kit and IL-17A) that were most abundant in severe asthma with mixed granulocytic airway inflammation. Intermediate ILC2s correlated with airway neutrophilia and were associated with increased amounts of IL-1β and IL-18 in sputum supernatants. Coculture of sort-purified canonical ILC2s with IL-1β and IL-18 in vitro up-regulated c-kit and IL-17A as well as gene expression profiles related to both type 2 and type 17 inflammatory pathways. Together, we have identified an intermediate-ILC2 phenotype in the airways of individuals with severe mixed granulocytic asthma, representing a candidate therapeutic target for controlling neutrophilic airway inflammation.